Colgate-Palmolive (NYSE:CL) Shares Purchased by Caprock Group LLC

Caprock Group LLC increased its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 49.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 28,879 shares of the company's stock after acquiring an additional 9,554 shares during the quarter. Caprock Group LLC's holdings in Colgate-Palmolive were worth $2,998,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. purchased a new stake in Colgate-Palmolive during the 2nd quarter worth approximately $25,000. Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $53,000. Finally, Gradient Investments LLC grew its position in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of CL traded up $0.30 during mid-day trading on Wednesday, reaching $93.91. The company's stock had a trading volume of 4,300,705 shares, compared to its average volume of 4,390,289. The company's fifty day moving average price is $98.80 and its two-hundred day moving average price is $98.56. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $75.39 and a 52 week high of $109.30. The stock has a market cap of $76.73 billion, a PE ratio of 26.90, a P/E/G ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.13%. Colgate-Palmolive's payout ratio is currently 57.31%.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Jefferies Financial Group cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price target for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Morgan Stanley raised their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a research note on Monday, July 29th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price target on the stock. Hsbc Global Res cut Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 26th. Finally, Barclays lifted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a research note on Monday, July 29th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Insider Activity

In other news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 16.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.